Financials

  • Market Capitalization 677.71 M
  • Employee 106
  • Founded 2016
  • CEO N/A
  • Website www.bridgebio.com
  • Headquarter Delaware, United States
  • FIGI BBG01L3GYF02
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.91
Relación precio/flujo de caja
34.38

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2688
CADL
Candel Therapeutics, Inc. - Common Stock
9.85 USD+2.18%0.00%+13.22%+51.54%721.71 M USD
2705
MNPR
Monopar Therapeutics Inc. - Common Stock
102.27 USD-1.03%+3.91%+69.04%+87.24%685.11 M USD
2718
RLMD
Relmada Therapeutics, Inc. - Common Stock
6.54 USD+1.40%+7.04%-1.95%+972.13%685.98 M USD
2722
PTCT
PTC Therapeutics, Inc. - Common Stock
79.82 USD-1.86%-6.84%+10.81%+61.45%662.10 M USD